share_log

Uncovering Potential: PDS Biotechnology's Earnings Preview

Uncovering Potential: PDS Biotechnology's Earnings Preview

揭示潜力:pds biotechnology 的收益预览
Benzinga ·  11/13 11:02

PDS Biotechnology (NASDAQ:PDSB) is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.

PDS Biotechnology(纳斯达克股票代码:PDSB)定于2024-11-14星期四发布其最新的季度收益报告。以下是投资者在宣布之前需要了解的内容。

Analysts estimate that PDS Biotechnology will report an earnings per share (EPS) of $-0.28.

分析师估计,PDS Biotechnology将公布的每股收益(EPS)为-0.28美元。

The announcement from PDS Biotechnology is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

PDS Biotechnology的宣布备受期待,投资者正在寻求超出预期的消息以及对下一季度的有利指导。

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

对于新投资者来说,值得注意的是,指导可能是股价走势的关键决定因素。

Past Earnings Performance

过去的收益表现

Last quarter the company beat EPS by $0.11, which was followed by a 0.98% drop in the share price the next day.

上个季度,该公司每股收益高出0.11美元,随后第二天股价下跌0.98%。

Here's a look at PDS Biotechnology's past performance and the resulting price change:

以下是PDS Biotechnology过去的表现以及由此产生的价格变化:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.34 -0.37 -0.44 -0.45
EPS Actual -0.23 -0.30 -0.35 -0.35
Price Change % -1.0% 1.0% 3.0% 1.0%
季度 2024 年第二季度 2024 年第一季度 2023 年第四季度 2023 年第三季度
每股收益估算 -0.34 -0.37 -0.44 -0.45
实际每股收益 -0.23 -0.30 -0.35 -0.35
价格变动% -1.0% 1.0% 3.0% 1.0%
bigjpg

Stock Performance

股票表现

Shares of PDS Biotechnology were trading at $2.96 as of November 12. Over the last 52-week period, shares are down 56.38%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

截至11月12日,PDS Biotechnology的股票交易价格为2.96美元。在过去的52周中,股价下跌了56.38%。鉴于这些回报率通常为负数,长期股东在本财报发布时可能会看跌。

To track all earnings releases for PDS Biotechnology visit their earnings calendar on our site.

要追踪PDS Biotechnology的所有财报,请访问我们网站上的财报日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动化内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发